CARGO Therapeutics, Inc.
CRGXDelisted Aug 19, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001966494
CARGO Therapeutics, Inc. was delisted on Aug 19, 2025; its insiders filed their last Form 4 on Aug 19, 2025; 117 institutions reported holding it in 13F filings for Q2 2025, worth $196.6M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 117
- Q2 2025, +3 vs. previous quarter
- 13F value
- $196.6M
- Reported value at the end of Q2 2025
- Superinvestors holding
- 0
- At the end of Q2 2025
Superinvestors holding CRGX, Q2 2025
No superinvestor reported holding CRGX at the end of Q2 2025.
Latest insider trades
Open-market purchases and sales by CARGO Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 (view filing) | Jul 2 | 1 day | Radhakrishnan AnupSee Remarks | SSale | −1.63K | $4.18 | −$6.82K | −1.3%120.8K after | |
| May 16, 2025 (view filing) | May 14 | 2 days | Radhakrishnan AnupSee Remarks | SSale | −27.4K | $3.84 | −$105.2K | −18.3%122.4K after | |
| Apr 8, 2025 (view filing) | Apr 3 | 5 daysLate | Radhakrishnan AnupSee Remarks | SSale | −1.63K | $4.00 | −$6.52K | −2.1%77.3K after | |
| Sep 20, 2024 (view filing) | Sep 18-19 | 2 days | Chapman GinaPresident & CEO | SSale | −10.1K | $25.07 | −$254.3K | −8.9%103.9K after | 2 lots10b5-1 |
| Sep 20, 2024 (view filing) | Sep 18 | 2 days | Radhakrishnan AnupChief Financial Officer | SSale | −1.60K | $25.28 | −$40.4K | −19.9%6.45K after | 10b5-1 |
| Jun 3, 2024 (view filing)9:45 PM ET | May 30 | 4 days | Akkaraju Srinivas and 2 others10% Owner | PPurchase | +294.0K | $17.00 | +$5.00M | +7.1%4.42M after | |
| Nov 16, 2023 (view filing)7:39 PM ET | Nov 14 | 2 days | Akkaraju Srinivas and 2 others10% Owner | PPurchase | +666.7K | $15.00 | +$10.0M | +19.3%4.12M after | |
| Nov 14, 2023 (view filing)7:08 PM ET | Nov 14 | Same day | Third Rock Ventures V, L.P. and 5 others10% Owner | PPurchase | +1.33M | $15.00 | +$20.0M | +281.4%1.81M after | |
| Nov 14, 2023 (view filing)4:32 PM ET | Nov 14 | Same day | Edelman Joseph and 3 othersOther: Former 10% Owner | PPurchase | +666.7K | $15.00 | +$10.0M | New position333.3K after | 2 lots |
Top 10 13F holders, Q2 2025
The largest institutional positions in CARGO Therapeutics, Inc. at the end of Q2 2025; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 6,916,945 | $28.5M | 0.00% | +1,638,141+31.0% | Added |
| Samsara BioCapital, LLC | 4,415,689 | $18.2M | 3.72% | 00.0% | Unchanged |
| Madison Avenue Partners, LP | 4,193,626 | $17.3M | 1.15% | +4,092,674+4,054.1% | Added |
| Cormorant Asset Management, LP | 3,381,277 | $13.9M | 1.04% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,059,630 | $12.6M | 0.64% | 00.0% | Unchanged |
| BlackRock, Inc. | 2,707,182 | $11.2M | 0.00% | −72,448−2.6% | Reduced |
| Nextech Invest, Ltd. | 2,642,502 | $10.9M | 2.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,053,200 | $8.46M | 0.00% | −24,169−1.2% | Reduced |
| TRV GP VI, LLC | 1,867,119 | $7.69M | 11.98% | 00.0% | Unchanged |
| TRV GP V, LLC | 1,737,216 | $7.16M | 4.32% | 00.0% | Unchanged |
Holders of 5% or more of CRGX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of CARGO Therapeutics, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Tang Capital Management LLC | 13D/A | 100.00%10.0K shares | +93.40 ppfrom 6.60% | Feb 21, 20253 filings | Aug 21, 2025 | SEC |
| Cormorant Asset Management, LP | 13G | 7.33%3.38M shares | New | May 15, 20251 filing | May 15, 2025 | SEC |